Received Dec 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
I am under 50 and already received my first dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate age at vaccine administration in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patients received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patients experienced inappropriate age at vaccine administration (Verbatim: I am under 50 and already received my first dose). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 11-DEC-2025 The patient was under 50 and already received first dose, and patient asked when can get the second one. The batch number was not provided, and we are unable to contact the reporter.